COPD in Women: Future Challenges.
COPD in Women: Future Challenges.
复制标题
女性慢性阻塞性肺病：未来的挑战。
DOI：
10.1016/j.arbres.2022.06.008
复制
发表时间：
2023
影响因子：
8
通讯作者：
Han,MeiLan
中科院分区：
文献类型：
--
作者：
Scicluna,Victoria;Han,MeiLan
背景慢性阻塞性肺疾病（COPD）一直是全世界死亡的主要原因，但从资金和公共卫生的角度来看，它作为发病率和死亡率的一个主要因素，并没有得到应有的关注。这可能是由于医学界和非专业界的误解造成的。慢性阻塞性肺病传统上被认为是一种老年吸烟男性的疾病，而不是被认为是一种影响男性和女性、年轻人和老年人、吸烟者和非吸烟者的普遍疾病。即使是医学文献中最知名的两种慢性阻塞性肺病的图像，“蓝色腹胀者”和“粉红河豚”，也描绘的是老年男性。荟萃分析估计，全球男性 COPD 患病率为 9-14%，女性为 6-8%。 1, 2 然而，随着时间的推移，男性和女性之间 COPD 患病率的差异似乎正在缩小。此外，女性的死亡率并没有像男性那样得到改善。 1, 3, 4
BackgroundChronic obstructive pulmonary disease (COPD) has been a leading cause of death worldwide, but has not garnered the attention it deserves as a major contributor to morbidity and mortality from both a funding and public health perspective. This may be due to misconceptions held both by the medical and lay communities. COPD has traditionally been considered a disease of older men who smoke rather than being recognized as a ubiquitous disease affecting men and women, young and old, smokers and non-smokers. Even the two most recognizable pictorial representations of COPD in the medical literature, the “Blue Bloater” and “Pink Puffer,” depict older men. Meta-analyses estimate the global prevalence of COPD among men is 9–14% and among women 6–8%. 1, 2 However, over time, differences in prevalence of COPD between men and women appear to be lessening. Further, women have not experienced the same improvements in mortality that have been seen among men. 1, 3, 4